Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury
In addition, patients experiencing nausea from these medications can consume high protein mini meals to ensure they are getting enough protein and essential vitamins and minerals even when it is hard to eat
Quick Answer: Success on GLP-1 medications requires a protein-first, fiber-rich eating strategy with 80-120g protein daily (20-35g per meal), 25-38g fiber, moderate healthy fats, and smaller, more frequent meals to manage side effects
Orlistat (Xenical/Alli), a lipase inhibitor available on the NHS, typically produces mean weight loss of around 35% compared with placebo over 12 months, making it a modest option for many patients
Doses such as 10 mg and 20 mg are usually designed for specific sustained-release formulations or high-concentration formulations, aiming to prolong the duration of drug effect, reduce the frequency of administration, and improve the convenience and compliance of long-term medication for patients
A 2023 observational study found no increased infection rates in GLP-1 users taking standard oral antibiotics, though infection duration was sometimes prolonged